polycythemia

(redirected from polycythemia vera)
Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to polycythemia vera: Polycythemia rubra vera

pol·y·cy·the·mi·a

 (pŏl′ē-sī-thē′mē-ə)
n.
A condition marked by an abnormally large number of red blood cells in the circulatory system.

ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.polycythemia - a disorder characterized by an abnormal increase in the number of red blood cells in the blood
blood disease, blood disorder - a disease or disorder of the blood
Translations

pol·y·cy·the·mi·a

n. policitemia, aumento excesivo de glóbulos rojos;
___ rubra___ vera secundaria, ___ vera;
primary ______ primaria.

polycythemia

n policitemia; — vera policitemia vera
References in periodicals archive ?
Cardiovascular events and intensity of treatment in polycythemia vera.
Polycythemia vera (PV) is a blood disorder in which the patient's bone marrow makes an excess of red blood cells.
In 1940, Dameshek and Henstell (1) described 20 cases of polycythemia vera (PV) and recognized certain symptoms, signs, and laboratory tests that, when pieced together, spelled out the diagnosis of "primary" or "true" polycythemia.
This report provides insights into the up-and-coming trends of the acquired orphan blood disorder pharmaceutical market by examining Idiopathic Thrombocytopenic Purpura (ITP), Myelodysplastic Syndrome (MDS), Myelofibrosis (MF), Paroxysmal Nocturnal Hemoglobinuria (PNH) and Polycythemia Vera (PV) in seven major markets: the US, the top five European countries (France, Germany, Italy, Spain and the UK) and Japan.
She had been admitted to another hospital in Istanbul about 6 months previously for the same symptoms, and she received a diagnosis of polycythemia vera after her blood counts were analyzed.
The WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis.
Chronic myeloproliferative disorders (CMPDs) are clonal haematopoietic stem cell disorders and include the BCR-ABL negative CMPDs like polycythemia vera (PV), essential thrombocythemia (ET), idiopathic myelofibrosis (IMF) and chronic eosinophilic leukaemia (CEL) (1,2).
The main area of focus for the JAK2 program has been the development of orally available JAK2 inhibitors to treat myeloproliferative disorders, which include myelofibrosis, polycythemia vera (PV) and essential thrombocythemia (ET).
Although the JAK2 mutation linked to ALL differs slightly from the defect in polycythemia vera patients, research into JAK2 inhibitors already under way for that disease could speed drug development for ALL patients with Down syndrome, Izraeli says.
Patients with Polycythemia Vera undergo therapeutic phlebotomies on a routine basis to decrease their hematocrit.
ONC8 SPLENOMEGALY WITH MASSIVE HEMORRHAGIC INFARCTION COMPLICATING POLYCYTHEMIA VERA.
His medical history revealed the presence of polycythemia vera (PV) diagnosed 13 years ago and treated with phlebotomy and hydroxyurea.